Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Headache and hemodialysis: a prospective study.

Ana L Antoniazzi1, Marcelo E Bigal, Carlos A Bordini

  • 1Department of Neurology, School of Medicine at Ribeirão Preto, São Paulo University, Brazil.

Headache
|February 1, 2003
PubMed
Summary

Headache is common in hemodialysis patients, affecting over 70%. While some headaches improve with dialysis, classifying them using standard criteria can be challenging.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same authorSame journal

Safety and tolerability of transnasal evaporative cooling for the acute treatment of migraine in an at-home setting: A randomized, double-blind, sham-controlled, decentralized clinical trial.

Headache·2026
Same author

Efficacy and safety of eptinezumab in adults with chronic migraine and medication-overuse headache who also received patient education: 24-week results of the randomized RESOLUTION trial.

The journal of headache and pain·2026
Same author

A retrospective cohort study comparing treatment persistence between rimegepant and lasmiditan for the acute treatment of migraine in the US.

Cephalalgia : an international journal of headache·2026
Same author

Benefits of eptinezumab on patient-reported disease burden and health-related quality of life in adults with chronic migraine and medication-overuse headache: Results from the placebo-controlled RESOLUTION trial.

Cephalalgia : an international journal of headache·2026
Same author

Integrated analysis of two randomized controlled trials of a digital therapeutic for episodic migraine prevention.

NPJ digital medicine·2026
Same author

Eptinezumab With Patient Education for Chronic Migraine and Medication-Overuse Headache: The Randomized, Placebo-Controlled RESOLUTION Trial.

Neurology·2026

Area of Science:

  • Nephrology
  • Neurology
  • Clinical Medicine

Background:

  • Headache is a frequent complaint among patients undergoing hemodialysis, with approximately 70% reporting this symptom.
  • Despite its prevalence, headaches in this patient population remain understudied.
  • Understanding headache patterns in hemodialysis patients is crucial for improving their quality of life.

Purpose of the Study:

  • To determine the prevalence and clinical characteristics of headaches in patients undergoing hemodialysis.
  • To compare headache prevalence before and after initiating hemodialysis.
  • To classify headaches in this cohort using the International Headache Society criteria.

Main Methods:

  • Prospective evaluation of 123 patients with chronic renal failure undergoing hemodialysis across three centers in Brazil (1998-1999).

Related Experiment Videos

  • Patients with headaches were classified according to International Headache Society criteria.
  • Headaches were categorized based on their temporal relationship to hemodialysis sessions.
  • Main Results:

    • Headache was reported by 70.7% of patients (87 out of 123).
    • Pre-dialysis, common diagnoses included migraine (48%) and episodic tension-type headache (19%). Headache related to arterial hypertension was also frequent (25.4%).
    • During hemodialysis, 57.5% experienced headaches, with 'dialysis headache' being the most common type (34 patients). Notably, 27.6% reported significant headache improvement post-dialysis initiation.

    Conclusions:

    • Headache is highly prevalent in patients undergoing hemodialysis.
    • Classifying headaches in hemodialysis patients according to established criteria can present difficulties.
    • Further research is needed to refine diagnostic and treatment strategies for headaches in this population.